Opioid lawsuit success bodes well for North Dakota
There are a number of reactions that could manifest as a result of the State of Oklahoma’s $572 million judgment against Johnson & Johnson announced this week as a result of the company’s alleged role in the spread of the opioid epidemic. While there is certain to be an appeal if a settlement isn’t reached, it still represents a breakthrough for state and local governments seeking compensation from “big pharma” when it comes to this epidemic. That’s a good thing. However, some may also take Oklahoma’s success as a sign that a state operating legally alone against ...